tiprankstipranks
Advertisement
Advertisement
Q32 Bio Launches Flexible $14.2 Million ATM Program
PremiumCompany AnnouncementsQ32 Bio Launches Flexible $14.2 Million ATM Program
2M ago
Q32 Bio Faces Governance Backlash and Rising Costs After 2025 Stock Option Repricing
Premium
Company Announcements
Q32 Bio Faces Governance Backlash and Rising Costs After 2025 Stock Option Repricing
3M ago
Positioning Bempikibart for Pivotal Development: De-Risked Economics, Strong Cash Runway, and a Catalyst-Rich 2026 Support Buy Rating
Premium
Ratings
Positioning Bempikibart for Pivotal Development: De-Risked Economics, Strong Cash Runway, and a Catalyst-Rich 2026 Support Buy Rating
3M ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
6M ago
Why Is Q32 Bio Stock (QTTB) Up Today?
Premium
Market News
Why Is Q32 Bio Stock (QTTB) Up Today?
6M ago
Q32 Bio Sells ADX-097 to Akebia Therapeutics
Premium
Company Announcements
Q32 Bio Sells ADX-097 to Akebia Therapeutics
6M ago
Q32 Bio reports Q3 EPS (60c), consensus ($1.19)
PremiumThe FlyQ32 Bio reports Q3 EPS (60c), consensus ($1.19)
6M ago
Q32 Bio Completes Enrollment for Alopecia Trial
Premium
Company Announcements
Q32 Bio Completes Enrollment for Alopecia Trial
7M ago
Q32 Bio completes enrollment in Part B of SIGNAL-AA trial
Premium
The Fly
Q32 Bio completes enrollment in Part B of SIGNAL-AA trial
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100